UK Biotech Biz Roquefort To Move To AIM After £30M Merger
Roquefort Therapeutics PLC said Wednesday that it plans to leave London's main market as its £30 million ($40.5 million) acquisition of Coiled Therapeutics Inc. "nears completion."...To view the full article, register now.
Already a subscriber? Click here to view full article